FERRARI, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.246
NA - Nord America 14.647
AS - Asia 1.932
SA - Sud America 101
AF - Africa 36
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 28
Totale 32.023
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.505
IT - Italia 8.302
GB - Regno Unito 3.344
CN - Cina 902
SE - Svezia 832
DE - Germania 642
UA - Ucraina 606
FR - Francia 399
HK - Hong Kong 396
FI - Finlandia 345
TR - Turchia 318
BG - Bulgaria 220
CH - Svizzera 144
CA - Canada 98
NL - Olanda 64
RU - Federazione Russa 63
IE - Irlanda 61
KR - Corea 60
IN - India 57
IR - Iran 50
ES - Italia 39
BE - Belgio 38
AU - Australia 31
MX - Messico 31
BR - Brasile 27
EU - Europa 24
GR - Grecia 24
VN - Vietnam 23
CO - Colombia 20
JP - Giappone 20
EG - Egitto 17
SG - Singapore 17
CZ - Repubblica Ceca 16
PE - Perù 16
EC - Ecuador 15
HU - Ungheria 15
MY - Malesia 15
CL - Cile 14
PH - Filippine 14
TW - Taiwan 14
DK - Danimarca 13
SK - Slovacchia (Repubblica Slovacca) 13
RO - Romania 11
PL - Polonia 10
PT - Portogallo 10
ZA - Sudafrica 9
MN - Mongolia 8
NO - Norvegia 8
ID - Indonesia 6
PK - Pakistan 6
AR - Argentina 5
IL - Israele 5
LT - Lituania 5
BO - Bolivia 4
CR - Costa Rica 4
LU - Lussemburgo 4
NG - Nigeria 4
RS - Serbia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
AT - Austria 3
BZ - Belize 3
EE - Estonia 3
PR - Porto Rico 3
SA - Arabia Saudita 3
SC - Seychelles 3
SI - Slovenia 3
TH - Thailandia 3
BH - Bahrain 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
DO - Repubblica Dominicana 1
HR - Croazia 1
IQ - Iraq 1
KW - Kuwait 1
MD - Moldavia 1
MT - Malta 1
MU - Mauritius 1
SM - San Marino 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
Totale 32.023
Salva come PNG Salva come JPEG
Città #
Southend 2.835
Fairfield 1.875
Woodbridge 1.380
Jacksonville 1.280
Chandler 1.146
Ashburn 943
Houston 933
Milan 840
Ann Arbor 727
Dearborn 708
Seattle 694
Wilmington 688
Cambridge 645
Nyköping 476
Hong Kong 391
Beijing 354
Rome 287
Princeton 255
Turin 246
Sofia 216
Eugene 205
Modena 204
Izmir 199
San Diego 173
Helsinki 157
Redwood City 144
Brescia 127
Florence 117
Genoa 114
Bologna 77
Falls Church 77
Des Moines 71
Monza 63
Bergamo 61
Verona 57
Norwalk 56
Dublin 54
New York 52
Parma 50
Boardman 48
Fremont 45
London 45
Nanjing 44
Shanghai 42
Bremen 41
Naples 41
Padova 37
Torino 37
Perugia 36
Palermo 35
Pescara 33
Tulare 33
Kunming 32
Catania 30
Hefei 30
Toronto 28
Brussels 27
Ottawa 27
Busto Arsizio 26
Trieste 26
Genova 23
Bari 22
Como 22
Dallas 20
Lucca 20
Mountain View 20
Piacenza 20
San Mateo 20
Dong Ket 19
Nanchang 19
Paris 19
La Spezia 18
Washington 18
Guangzhou 17
Hounslow 17
Udine 17
Indiana 16
Jinan 15
Leawood 15
Salerno 15
Kilburn 14
Lausanne 14
Novara 14
Siena 14
Zurich 14
Dalmine 13
Los Angeles 13
Mariano Comense 13
Napoli 13
Treviso 13
Alessandria 12
Ferrara 12
Istanbul 12
Pavia 12
Riposto 12
Trento 12
Verdellino 12
Ardabil 11
Corsico 11
Dongguan 11
Totale 20.344
Salva come PNG Salva come JPEG
Nome #
Monitoraggio dei pazienti con uso/abuso alcolico mediante la determinazione dell'Etil glucuronide (EtG) nel capello 6.149
Krokodil: The drug that kills 1.312
La flunarizina nella profilassi delel crisi emicraniche delle cefalee cclassiche e comuni 723
Allopregnanolone serum levels in female migraineurs 570
Seizures of illicit substances for personal use in two Italian provinces: analysis of trends by type and purity from 2008 to 2017 536
Monitoring of adherence to headache treatments by means of hair analysis 292
Tramadol chronic abuse: An evidence from hair analysis by LC tandem MS 281
Hair analysis for detection of triptans occasionally used or overused by migraine patients-a pilot study 270
OPPIACEI: FARMACOCINETICA, DIPENDENZA, DETOSSIFICAZIONE, TRATTAMENTI AGONISTI ED ANTAGONISTI 247
The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors 239
Hair testing in clinical setting: simultaneous determination of 50 psychoactive drugs and metabolites in headache patients by LC tandem MS 233
Headache treatment before and after the consultation of a specialized centre: a pharmacoepidemiology study 212
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 209
Adverse reactions related to drugs for headache treatment: clinical impact 208
Development and validation of a liquid chromatography-tandem mass spectrometric assay for quantitative analyses of triptans in hair 207
Methadone - metabolism, pharmacokinetics and interactions 204
Hair analysis to monitor abuse of analgesic combinations containing butalbital and propyphenazone 200
Effect of overuse of the antimigraine combination of indomethacin, prochlorperazine and caffeine (IPC) on the disposition of its components in chronic headache patients 198
Paracetamol: new vistas of an old drug 193
Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study 190
Interindividual variability of oral sumatriptan pharmacokinetics and of clinical response in migraine patients 189
Polypharmacy Among Headache Patients: A Cross-Sectional Study 188
Farmacologia e Tossicologia 187
Effective prophylactic treatments of migraine lower plasma glutamate levels 186
Clinical pharmacology of topiramate in migraine prevention 184
Diagnostic accuracy of hair analysis for the detection of triptan overuse in migraineurs 184
Analgesic drug taking: Beliefs and behavior among headache patients 184
Past, present, and future prospects of medication-overuse headache classification 181
PHARMACOKINETIC OF REDUCED GLUTATHIONE IN MAN - EFFECT ON PLASMA CYSTEINE AND THIOL COMPOUNDS 180
Similarities and differences between chronic migraine and episodic migraine 179
Medication overuse and chronic migraine: a critical review according to clinical pharmacology 178
Effect of sumatriptan in different models of pain in rats 177
Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia/reperfusion injury in rats 174
Pharmacokinetics and interactions of headache medications, part II: prophylactic treatments 174
Basal cutaneous pain threshold in headache patients 172
Topiramate-associated acute glaucoma in a migraine patient receiving concomitant citalopram therapy: a case-report 168
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 168
Why pharmacokinetic differences among oral triptans have little clinical importance: a comment. 166
Need for analgesics/drugs of abuse: a comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ) 162
The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients 162
How children and parents evaluate the headache centre's intervention 162
Pharmacokinetics and interactions of headache medications, part I: introduction, pharmacokinetics, metabolism and acute treatments 162
Focus on headache as an adverse reaction to drugs 162
Headache: one of the most common and troublesome adverse reactions to drugs. 161
Pharmacoepidemiology of triptans in a headache centre 161
Tramadol Abuse in a Binge Pattern in a Young Depressed Woman 159
Emerging problems in the pharmacology of migraine: interactions between triptans and drugs for prophylaxis 157
Prevalence of abuse of alcohol and other drugs among injured drivers presenting to the emergency department of the University Hospital of Modena, Italy 156
Glutamate receptor antagonists with the potential for migraine treatment 152
Pharmacokinetics of indomethacin in chronic migraine patients after withdrawal from the overused combination of indomethacin, Prochlorperazine and caffeine 151
INFLUENCE OF PROLONGED THERAPY WITH FLUNARIZINE ON GLUCOSE, INSULIN AND C-PEPTIDE METABOLISM 150
Serum time course of naltrexone and 6 beta-naltrexol levels during long term treatment in drug addicts 149
Intrapatient variability of the hair levels of pain medications in chronic migraine patients - a pilot study 147
Pharmacokinetics of sumatriptan in non-respondent and in adverse drug reaction reporting migraine patients 145
Italian guidelines for primary headaches: 2012 revised version. 144
Hypertension and migraine comorbidity: Prevalence and risk of cerebrovascular events: Evidence from a large, multicenter, cross-sectional survey in Italy (MIRACLES study) 142
Analgesia and endocrine surgical stress: effect of two analgesia protocols on cortisol and prolactin levels during abdominal aortic aneurysm endovascular repair. 141
Abuse of tramadol in a binge pattern in a young woman 141
Oral delivery of insulin loaded into polymeric nanoparticles in rats. 140
Analgesic abuse in chronic headache sufferers 139
Proteomic serum profile in menstrual-related and post menopause migraine 139
Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial. 138
Plasma glutathione level in chronic headache drug abuser patients 137
Clinical considerations preliminary to application of the Italian Society for the Study of Headache’s guidelines regarding migraine prophylactic treatment 135
Effect of gamma-hydroxybutyrate in two rat models of focal cerebral damage 135
Trattamento farmacologico integrato per la terapia delle tossicodipendenze 135
Abuso di sostanze psicoattive e sistema neuroendocrino dell’adolescente 133
Zopiclone and prazepam abuse in a chronic migraine patient 133
Naltrexone: aspetti di farmacologia ed applicazioni cliniche 130
Paracetamol revisited 129
Sucrose intake: Increase in non-stressed rats and reduction in chronically stressed rats are both prevented by the gamma-hydroxybutyrate (GHB) analogue, GET73 127
Storia della Sindrome di Neri Barrè 127
Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review 127
Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey 126
Hair testing as a marker of adherence to headache treatments 118
Pharmacological treatment of drug dependence in daily chronic headache sufferers 118
Plasma glutathione level in paracetamol daily abuser patients. Changes in plasma cysteine and thiol groups after reduced glutathione administration 118
Pharmacokinetics of indomethacin in chronic migraine patients after withdrawal of the overused combination of indomethacin, prochlorperazine, and caffeine 117
Chronic treatment with naltrexone and hepatic functions in heroin addicts 115
Prophylaxis of food-induced migraine with cromolyn sodium: efficacy of short and long-term use 115
Zopiclone and prazepam dependance: role of hair analysis for the monitoring of treatment in a migraine patient 114
Adolescenza, sostanze stupefacenti, riti di passaggio 114
Evaluation of the analgesic effect of nabilone versus acetaminophen plus caffeine in an inflammatory pain model (tail flik test) in rats. 114
Effects of long-term treatment with naltrexone on hepatic enzyme activity. 113
Pharmacological outline of chronic headache patients: overlap between depressive and nociceptive symptomatology 112
Un caso complesso di medication-overuse headache e dipendenza da ipnoinducenti: ruolo dell’analisi del capello per il monitoraggio del trattamento. 112
INFLUENCE OF FLUNARIZINE ON THE ALTERED ELECTRONYSTAGMOGRAPHIC (ENG) RECORDINGS IN MIGRAINE 111
Different effect of sumatriptan in models of thermal, chemical or cephalalgic pain, in rats 111
Headache as an Adverse Reaction to Medication 109
Accanimento terapeutico o riduzione del danno 109
Trattamento farmacologico del dolore postoperatorio 108
Folate, vitamin B12, and serum homocysteine levels in patients with chronic migraine and medication-overuse headache 104
Activity of cromolyn sodium in dietary migraine: a double-blind placebo controlled multicenter trial 103
Proteomic serum profile of female migraineurs 102
Clinical pharmacology of topiramate in migraine prophylaxis: efficacy and safety 101
Drug metabolism in liver cirrhosis: alterations of the time-course of plasma naltrexone levels after oral intake 101
CHRNA5 polymorphism and nicotine dependence in patients with cluster headache 101
Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study 101
Pharmacoepidemiology of triptans in a headache centre 100
Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, multicentre study 99
Totale 23.928
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.852
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.852
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.403 0 0 0 0 0 0 0 0 0 0 613 790
2019/20205.902 368 375 244 403 614 774 1.002 547 555 265 457 298
2020/20215.271 575 274 479 322 574 297 435 716 225 673 448 253
2021/20224.493 169 519 430 465 191 223 256 296 449 315 568 612
2022/20235.226 494 438 281 409 526 604 248 531 682 252 426 335
2023/20245.189 276 362 371 578 746 468 719 722 389 501 57 0
Totale 32.284